Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
The announcements reflect a calculated shift from discrete chip sales to integrated systems that address enterprise ...
Multiple myeloma may cause pain in the back, legs, hips, ribs, and stomach due to bone damage and excess calcium release. Treatments for multiple myeloma pain may range from over-the-counter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback